Where Will C3.ai Stock Be in 1 Year?

C3.ai, an enterprise AI software provider, has demonstrated a revenue growth recovery and gross margin stabilization in fiscal years 2024 and 2025, driven by new federal contracts, strategic partnerships, and the critical three-year renewal of its joint venture with top client Baker Hughes. Despite this operational improvement and projected 15-25% revenue growth for FY26, the company continues to report substantial adjusted operating losses, with profitability not anticipated in the near term, and its stock is expected to remain significantly below its IPO price despite potential modest gains.

Analysis

C3.ai (AI) is demonstrating a notable operational turnaround, with revenue growth accelerating from 6% in fiscal 2023 to a stabilized rate above 20% in recent quarters, and projecting 15-25% growth for fiscal 2026. This recovery is underpinned by new federal contracts, strategic partnerships with major cloud providers, and the critical three-year renewal of its joint venture with Baker Hughes, which accounts for over 30% of revenue and significantly de-risks the near-term outlook. Concurrently, adjusted gross margins have stabilized and begun to recover, expanding to 71% in Q4 2025 as the company successfully converts low-margin pilot programs into full-priced deployments. However, this top-line progress comes at a significant cost to profitability. The company has explicitly abandoned its near-term goal of adjusted profitability to fund growth investments, guiding for an adjusted operating loss of $65 million to $100 million in FY26, showing no material improvement over FY25's $88 million loss. Furthermore, stock-based compensation remains a major concern, consuming 59% of FY25 revenue at $231 million, which suggests substantial ongoing shareholder dilution and contributes to a projected widening of the GAAP net loss to $302 million in FY26.

Key Decisions for Investors

• Investors should weigh the re-accelerating revenue growth and de-risking from the Baker Hughes contract renewal against the company's lack of a clear path to profitability and significant shareholder dilution.
• Monitor adjusted gross margins and the customer diversification progress closely, as improvements in these areas are critical for justifying the company's valuation at 8 times forward sales.
• Be cautious of the high stock-based compensation, which consumed 59% of FY25 revenue, and the widening GAAP net losses, as these factors may cap share price appreciation despite positive top-line momentum.
• Given the forecast for modest potential upside to a price point still well below its IPO level, consider C3.ai a high-risk, speculative holding within a diversified portfolio, rather than a core position.